Skip to Main Content

Author Details

Timothy R Zacharewski
Institute for Integrative Toxicological Sciences, Michigan State University
1987
175
52
PMIDPaper TitleJournal TitlePublished Year
36222588Single-cell transcriptomics shows dose-dependent disruption of hepatic zonation by TCDD in mice.Toxicol Sci2023
37789023Characterizing the impact of simvastatin co-treatment of cell specific TCDD-induced gene expression and systemic toxicity.Sci Rep2023
37602218Generative modeling of single-cell gene expression for dose-dependent chemical perturbations.Patterns (N Y)2023
37352010A Case for Accelerating Standards to Achieve the FAIR Principles of Environmental Health Research Experimental Data.Environ Health Perspect2023
37184393Cystine/Glutamate Xc<sup>-</sup> Antiporter Induction Compensates for Transsulfuration Pathway Repression by 2,3,7,8-Tetrachlorodibenzo-<i>p</i>-dioxin (TCDD) to Ensure Cysteine for Hepatic Glutathione Biosynthesis.Chem Res Toxicol2023
36914879Consequences of reprogramming acetyl-CoA metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse liver.Sci Rep2023
35061903Benchmarking of a Bayesian single cell RNAseq differential gene expression test for dose-response study designs.Nucleic Acids Res2022
36422908A Physiologically Based Pharmacokinetic (PBPK) Modeling Framework for Mixtures of Dioxin-like Compounds.Toxics2022
35931118Dioxin-elicited decrease in cobalamin redirects propionyl-CoA metabolism to the β-oxidation-like pathway resulting in acrylyl-CoA conjugate buildup.J Biol Chem2022
35163483Genome-Wide ChIPseq Analysis of AhR, COUP-TF, and HNF4 Enrichment in TCDD-Treated Mouse Liver.Int J Mol Sci2022
32791302Single-Nuclei RNA Sequencing Assessment of the Hepatic Effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin.Cell Mol Gastroenterol Hepatol2021
33720361Genetics-Based Approach to Identify Novel Genes Regulated by the Aryl Hydrocarbon Receptor in Mouse Liver.Toxicol Sci2021
34830313Aryl Hydrocarbon Receptor (AhR) Activation by 2,3,7,8-Tetrachlorodibenzo-<i>p</i>-Dioxin (TCDD) Dose-Dependently Shifts the Gut Microbiome Consistent with the Progression of Non-Alcoholic Fatty Liver Disease.Int J Mol Sci2021
34344994Thioesterase induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin results in a futile cycle that inhibits hepatic β-oxidation.Sci Rep2021
323871832,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters hepatic polyunsaturated fatty acid metabolism and eicosanoid biosynthesis in female Sprague-Dawley rats.Toxicol Appl Pharmacol2020
31728591Gene co-regulation and co-expression in the aryl hydrocarbon receptor-mediated transcriptional regulatory network in the mouse liver.Arch Toxicol2020
31881176A toxicogenomic approach for the risk assessment of the food contaminant acetamide.Toxicol Appl Pharmacol2020
329081892,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) dysregulates hepatic one carbon metabolism during the progression of steatosis to steatohepatitis with fibrosis in mice.Sci Rep2020
310154832,3,7,8-Tetrachlorodibenzo-p-dioxin abolishes circadian regulation of hepatic metabolic activity in mice.Sci Rep2019
31676775Characterizing the Role of HMG-CoA Reductase in Aryl Hydrocarbon Receptor-Mediated Liver Injury in C57BL/6 Mice.Sci Rep2019
29752288Comparison of Hepatic NRF2 and Aryl Hydrocarbon Receptor Binding in 2,3,7,8-Tetrachlorodibenzo-<i>p</i>-dioxin-Treated Mice Demonstrates NRF2-Independent PKM2 Induction.Mol Pharmacol2018
296738562,3,7,8-Tetrachlorodibenzo-p-dioxin dose-dependently increases bone mass and decreases marrow adiposity in juvenile mice.Toxicol Appl Pharmacol2018
29501526Corrigendum to "Convergence of hepcidin deficiency, systemic iron overloading, heme accumulation, and REV-ERBα/β activation in aryl hydrocarbon receptor-elicited hepatotoxicity" [Toxicol. Appl. Pharmacol. 321 (2017) 1-17].Toxicol Appl Pharmacol2018
27913140Comparative analysis of TCDD-induced AhR-mediated gene expression in human, mouse and rat primary B cells.Toxicol Appl Pharmacol2017
28475713TCDD influences reservoir of antibiotic resistance genes in murine gut microbiome.FEMS Microbiol Ecol2017
28213091Convergence of hepcidin deficiency, systemic iron overloading, heme accumulation, and REV-ERBα/β activation in aryl hydrocarbon receptor-elicited hepatotoxicity.Toxicol Appl Pharmacol2017
28238261Lipidomic Evaluation of Aryl Hydrocarbon Receptor-Mediated Hepatic Steatosis in Male and Female Mice Elicited by 2,3,7,8-Tetrachlorodibenzo-p-dioxin.Chem Res Toxicol2017
28948239Beyond the Aryl Hydrocarbon Receptor: Pathway Interactions in the Hepatotoxicity of 2,3,7,8-Tetrachlorodibenzo-<i>p</i>-dioxin and Related Compounds.Curr Opin Toxicol2017
287250012,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-elicited effects on bile acid homeostasis: Alterations in biosynthesis, enterohepatic circulation, and microbial metabolism.Sci Rep2017
28922406Loss of liver-specific and sexually dimorphic gene expression by aryl hydrocarbon receptor activation in C57BL/6 mice.PLoS One2017
26203683Ozone-Induced Type 2 Immunity in Nasal Airways. Development and Lymphoid Cell Dependence in Mice.Am J Respir Cell Mol Biol2016
26582802Pyruvate Kinase Isoform Switching and Hepatic Metabolic Reprogramming by the Environmental Contaminant 2,3,7,8-Tetrachlorodibenzo-p-Dioxin.Toxicol Sci2016
27613713From the Cover: Coagulation-Driven Hepatic Fibrosis Requires Protease Activated Receptor-1 (PAR-1) in a Mouse Model of TCDD-Elicited Steatohepatitis.Toxicol Sci2016
27562557Dose-Dependent Metabolic Reprogramming and Differential Gene Expression in TCDD-Elicited Hepatic Fibrosis.Toxicol Sci2016
26921287Fibrin deposition following bile duct injury limits fibrosis through an αMβ2-dependent mechanism.Blood2016
25274660Development of a computational high-throughput tool for the quantitative examination of dose-dependent histological features.Toxicol Pathol2015
263776472,3,7,8-Tetrachlorodibenzo-p-Dioxin Alters Lipid Metabolism and Depletes Immune Cell Populations in the Jejunum of C57BL/6 Mice.Toxicol Sci2015
26377646Atrazine-Mediated Disruption of Steroidogenesis in BLTK1 Murine Leydig Cells.Toxicol Sci2015
26422241Loss of Hif-2α Rescues the Hif-1α Deletion Phenotype of Neonatal Respiratory Distress In Mice.PLoS One2015
25958198RNA-Seq versus oligonucleotide array assessment of dose-dependent TCDD-elicited hepatic gene expression in mice.BMC Genomics2015
22977169TCDD-elicited effects on liver, serum, and adipose lipid composition in C57BL/6 mice.Toxicol Sci2013
24096037o-p'-DDT-mediated uterotrophy and gene expression in immature C57BL/6 mice and Sprague-Dawley rats.Toxicol Appl Pharmacol2013
23864506Toxicogenomic evaluation of long-term hepatic effects of TCDD in immature, ovariectomized C57BL/6 mice.Toxicol Sci2013
23994337Comparisons of differential gene expression elicited by TCDD, PCB126, βNF, or ICZ in mouse hepatoma Hepa1c1c7 cells and C57BL/6 mouse liver.Toxicol Lett2013
23811191PPARα-mediated responses in human adult liver stem cells: In vivo/in vitro and cross-species comparisons.J Steroid Biochem Mol Biol2013
23418086Comparative analysis of temporal and dose-dependent TCDD-elicited gene expression in human, mouse, and rat primary hepatocytes.Toxicol Sci2013
23591565Triazine herbicides and their chlorometabolites alter steroidogenesis in BLTK1 murine Leydig cells.Toxicol Sci2013
23238561Comparison of TCDD-elicited genome-wide hepatic gene expression in Sprague-Dawley rats and C57BL/6 mice.Toxicol Appl Pharmacol2013
21964420Comparative metabolomic and genomic analyses of TCDD-elicited metabolic disruption in mouse and rat liver.Toxicol Sci2012
22539624Dietary fat is a lipid source in 2,3,7,8-tetrachlorodibenzo-ρ-dioxin (TCDD)-elicited hepatic steatosis in C57BL/6 mice.Toxicol Sci2012
  • 1 - 50 of 175

Recommended Authors

Ontario Institute for Cancer Research, University of Toronto
Career Start Year 2014
Number of shared co-authors 1
University of California los angeles
Career Start Year 2013
Number of shared co-authors 1
University Health Network
Career Start Year 2011
Number of shared co-authors 1
Oregon State University
Career Start Year 2006
Number of shared co-authors 0
INSERM UMR-S1124, Universite Paris Cite
Career Start Year 2005
Number of shared co-authors 1
Gladstone Institutes
Career Start Year 2004
Number of shared co-authors 0
University of Toronto
Career Start Year 2004
Number of shared co-authors 3
Oregon State University
Career Start Year 2003
Number of shared co-authors 0
Career Start Year 2001
Number of shared co-authors 1
National Center for Toxicological Research (NCTR)
Career Start Year 2000
Number of shared co-authors 0
National Institute of Environmental Health Sciences
Career Start Year 2000
Number of shared co-authors 1
University of North Carolina
Career Start Year 1998
Number of shared co-authors 0
University of Ottawa
Career Start Year 1996
Number of shared co-authors 1
Institute for Global Food Security, Queen's University Belfast
Career Start Year 1994
Number of shared co-authors 0
Pacific Northwest National Laboratory
Career Start Year 1994
Number of shared co-authors 0
F. Hoffmann-La Roche Ltd
Career Start Year 1993
Number of shared co-authors 0
North Carolina State University, USA Center for Human Health and the Environment
Career Start Year 1993
Number of shared co-authors 0
Ontario Institute for Cancer Research
Career Start Year 1993
Number of shared co-authors 1
University of Helsinki
Career Start Year 1989
Number of shared co-authors 2
Finnish Institute for Health and Welfare
Career Start Year 1989
Number of shared co-authors 1
Woods Hole Oceanographic Institution
Career Start Year 1986
Number of shared co-authors 0
Maastricht University
Career Start Year 1981
Number of shared co-authors 0
School of Pharmacy (Toxicology), University of Eastern Finland
Career Start Year 1981
Number of shared co-authors 2
Department of Food Hygiene and Environmental Health, University of Helsinki
Career Start Year 1981
Number of shared co-authors 4
National Institute of Environmental Health Sciences
Career Start Year 1980
Number of shared co-authors 1
School of Pharmacy, University of Louisiana at Monroe
Career Start Year 1980
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 1978
Number of shared co-authors 0
Institute of Environmental Medicine, Karolinska Institutet
Career Start Year 1976
Number of shared co-authors 1
Center for Research and Advanced Studies of the National Polytechnic Institute
Career Start Year 1976
Number of shared co-authors 1
University of Toronto
Career Start Year 1968
Number of shared co-authors 4

Collaborators

National Center for Environmental Assessment
Co-authored papers 38
Institute of Basic Medical Sciences, University of Oslo
Co-authored papers 19
Genentech Inc.
Co-authored papers 15
Co-authored papers 11
Co-authored papers 10
University of Toronto
Co-authored papers 5
Co-authored papers 4
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
University of Toronto.
Co-authored papers 1
University of Virginia
Co-authored papers 1
College Station
Co-authored papers 1
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Mayo Clinic
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University of Louisville
Co-authored papers 1
Co-authored papers 1